Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

Crinetics Pharmaceuticals, Inc. | CRNX

Daily Technical Analysis of Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals is up a bit on the day, funds flowing in kept the price up 2.81% since yesterday.

The company isn't at an immediate support or resistance level that might be predictive. Crinetics Pharmaceuticals has looked pretty good over the last few months. It has definitely cuaght a bid and had a nice run. Over the last 3 months, shareholders are up 19.12 percent. CRNX might find some support at the 24 level, buyers might push the price back up from here. But it's not very clear what will happen.


Last analyzed on 2024-03-17

Analyst Ratings for Crinetics Pharmaceuticals By Price Target And Rating

The analysts feel pretty optimistic about Crinetics Pharmaceuticals and have been assigning positive ratings. The current Analysts Sentiment Score is 230.72. Most companies range between (-200 to 200).

Here's a break down of the latest rating changes. JMP Securities reiterated a rating of Market Outperform on 2024-03-28 and added a price target of $80.00. Jonestrading boosted their price targ by 7.69% to $56.00 on 2024-03-20. Oppenheimer gave a boost to their price target and moved to $55.00 from $54.00 on 2024-03-20. On 2024-03-19 HC Wainwright reiterated their rating of Buy and added a price target of $50.00. Citigroup initiated a rating of Buy on 2024-03-06 and provided a price target of $68.00. Cantor Fitzgerald boosted their price targ by 30% to $65.00 on 2024-03-04. Robert W. Baird provided a price target boost of 15.56% to $52.00 from $45.00 on 2024-02-29. On 2024-01-16 Morgan Stanley initiated their coverage and rated as Overweight and added a price target of $50.00. Jefferies Financial Group initiated a rating of Hold on 2023-12-21 and provided a price target of $35.00. JPMorgan Chase & Co. announced that they are reiterating a rating of Overweight on 2023-11-20 and they set their price target at $35.00.

Company Ratings Score ?
Composite analyst sentiment score
Positive Ratings Negative Ratings Boost Price Target Lower Price Target
CRNX230.72232.030229.410

Earnings Per Share (EPS) Estimates By Year and Quarter

(updated 2024-04-09)
Company YOY Growth Score (typical -20 to +20) Revision Directions (-6 to +6)
CRNX0.000.00

Short interest for Crinetics Pharmaceuticals

We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.

Company Short Score (typical 1-15) ?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
Short Interest Days to Cover Rate of Change Shares Short
CRNX10.35%10.29794.750.496810000

Social Sentiment for Crinetics Pharmaceuticals

Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.

Ticker Social Sentiment(1-10)
CRNX

Companies with the highest correlation to Crinetics Pharmaceuticals

Company Score 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Score
ACCD | Accolade, Inc. Common Sto0.61-3.54-19.91-20.43-43.3013.23-39.5233-1.13-0.552.67-13860.57170.04004.61812
DNLI | Denali Therapeutics Inc. 0.614.668.02-14.90-2.83-14.18-33.7244-10.54-23.64-26.73-17158.84-1907.180011.2371
FROG | JFrog Ltd. Ordinary Share0.59-1.00-2.45-7.4514.2075.54116.4546146.8871.2891.20-1791.57-9.32002.41447
ARWR | Arrowhead Research Corpor0.572.435.94-11.26-30.21-5.77-34.51230.930.943.65-3985.05-1395.56007.83995
PLUG | Plug Power Inc.0.56-0.43-3.36-26.98-48.78-60.95-73.2228-63.70-55.71-72.72-91323.20-777.330017.5707
STRO | Sutro Biopharma, Inc.0.5610.169.36-23.98-22.2536.00-18.70297.115.4416.01-20098.55-3641.2901255.27809
ALTR | Altair Engineering Inc. C0.541.19-2.12-2.46-8.2131.0520.632323.3727.0040.91-2796.56-17377.75007.39914
DENN | DENNY'S CORP0.530.25-2.55-5.30-20.94-6.73-28.2820-6.68-6.47-6.55-19358.78-541.31005.37919

Top 3 correlating companies

See full charts for all peers

Sentiment Score

How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.

Earnings Estimates
Analyst Rating
Price Targets
Short Interest
Financials
Options Sentiment
Institutional Ownership
Social Sentiment
Fidelity Summary
Overall Summary Notes
Calculated Sentiment Sum

Score Sum
(1-45)

/

Average
(1-5)

+

Pattern Rank
(1-5)

=

Total Score
(1-10)

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-